Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Datashil 20 mg Tablet
Manufacturer/Marketed By : Shilpa Medicare Ltd
$33.64 $24.02
Datashil 20 mg Tablet is a targeted anti-cancer therapy that features dasatinib as its active ingredient, primarily designed for the management of specific malignancies, including chronic myeloid leukemia (CML), a...
Dasatinib 20 mg
Active Pharmaceutical Ingredient
Datashil 20 mg Tablet
$33.64
$24.02
Datashil 20 mg Tablet is a targeted anti-cancer therapy that features dasatinib as its active ingredient, primarily designed for the management of specific malignancies, including chronic myeloid leukemia (CML), a blood cancer characterized by the overproduction of white blood cells. By inhibiting certain proteins involved in cancer cell growth, Datashil effectively reduces the proliferation of these abnormal cells, thereby helping to control the disease. Patients considering this treatment should be aware of potential side effects, which may include fatigue, fluid retention, and gastrointestinal disturbances, and should consult their healthcare provider regarding any existing medical conditions or medications to avoid adverse interactions. Regular monitoring of blood counts is also recommended during treatment to assess the drug's effectiveness and ensure safety. As an essential component of a comprehensive cancer treatment plan, Datashil 20 mg Tablet can significantly improve the quality of life for individuals battling CML. Always follow your healthcare professional's guidance when using this medication to maximize its benefits while minimizing risks. With its proven efficacy, Datashil stands as a vital option in the ongoing fight against cancer, empowering patients on their journey to recovery.
Active Pharmaceutical Ingredient
Uses
• Datashil 20 mg tablet is primarily utilized in the management of chronic myeloid leukemia (CML), a cancer that impacts blood and bone marrow. This medication helps to reduce the proliferation of abnormal cells, thereby improving the patient's overall health. Individuals diagnosed with CML often experience symptoms like fatigue and an enlarged spleen, which Datashil 20 mg tablet can help alleviate. Regular use of this medication may contribute to better disease control and quality of life for patients.
• In addition to CML, Datashil 20 mg tablet is effective for treating acute lymphoblastic leukemia (ALL). This type of leukemia is characterized by rapid growth of immature white blood cells, leading to various health complications. Datashil 20 mg tablet works by targeting specific cellular pathways, helping to slow down the progression of the disease. Patients suffering from symptoms such as easy bruising or frequent infections may find relief through this treatment.
• The application of Datashil 20 mg tablet is crucial for patients who require targeted therapy in their leukemia treatment plan. By focusing on the underlying mechanisms of leukemia, this medication allows for a more personalized approach to patient care. Healthcare providers often prescribe Datashil 20 mg tablet in conjunction with other therapies to enhance treatment outcomes. This comprehensive strategy can lead to improved management of both CML and ALL.
• Datashil 20 mg tablet is also indicated for patients who have not responded adequately to prior therapies for leukemia. Its mechanism of action provides an alternative option for those with resistant disease. By inhibiting specific enzymes involved in cancer cell proliferation, Datashil 20 mg tablet helps restore some level of control over the disease. This aspect is particularly valuable for patients facing challenging treatment scenarios.
Benefits
Datashil 20 mg Oral Tablet is effective and has a high rate of response in people with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia. It decreases the number of cancer cells in the blood and bone marrow and improves blood counts in people with CML or ALL. Dasatinib 20 mg Tablet is usually taken once a day, which may be more convenient for some people compared to other treatments. Datashil 20 mg is effective in people with CML or ALL who have not responded to other treatments.
Side Effects
Datashil 20 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Fever
• Nausea
• Nomiting
• Bleeding
• Skin rash
• Diarrhea
• Infection
• Bone marrow suppression
• Pleural effusion
• Abdominal pain
Common Side Effects
• Difficulty breathing
• Headache
• Tiredness
• Fatigue
• Muscle and joint pain
• Swelling in the hands and feet
How To Use
Datashil Anti-Cancer Tablet may be taken with or without food. Take it at the same time each day. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Datashil 20 mg Oral Tablet. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Dasatinib 20 mg Tablet and report any unusual symptoms or changes in kidney function to their physician. The dose of Datashil 20 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Dasatinib 20 mg Tablet. Datashil 20 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Datashil 20 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Datashil Anti-Cancer Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Datashil 20 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Dasatinib Cancer Medicine may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dasatinib Cancer Medicine may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Datashil 20 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dasatinib Cancer Medicine may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Datashil 20 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.